NCT03275610
Genetic Markers of Patients With History of Pulmonary Embolism Post Total Joint Arthroplasty
Enrolling by Invitation
Not specifiedAges 18–70ObservationalUniversity of Southern CaliforniaInvestigator-initiated
~100 participants
Updated 2026-05-04 on ClinicalTrials.gov
What's tested:Blood sample
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Identification of Genetic Mutations
Measured over 6 weeks Post Total Hip Arthroplasty or Post Total Knee Arthroplasty
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Study leadership
- Jay R Lieberman, MD · PRINCIPAL_INVESTIGATOR · University of Southern California
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
patients with a history of Pulmonary Embolism and Total Hip Arthroplasty or Total Knee Arthroplasty, between the ages of 18 and 70 years
What this trial measures
- Identification of Genetic Mutations6 weeks Post Total Hip Arthroplasty or Post Total Knee Arthroplasty
identify the frequency of genetic mutations in patients who have developed a PE after a total joint or total hip arthroplasty